Figure 1.

Hepatocyte-specific NEMO-deleted mice (NEMOΔhepa) are protected against Fas-mediated apoptosis. (A) Survival curve after i.p. injection of 0.5 µg/g Jo2, evidencing the resistance of NEMOΔhepa mice to Fas-mediated death. (B–D) Macroscopic view of livers 3 h after Jo2 (B), liver weight/body weight ratio (B), serum transaminases (C), and H&E staining (D) showed fulminant hepatitis in NEMOf/f mice after Jo2, whereas NEMOΔhepa remained unaffected. (E and F) TUNEL (E) and caspase 8 and 3 (F) activity analysis confirmed Jo2 apoptosis. Activity is represented in times versus untreated NEMOf/f. (G and H) Fas mRNA and IHC analysis in whole liver (G) and isolated primary hepatocytes (H) showed stronger expression in WT compared than in NEMOΔhepa mice. (I) TNF mRNA and cellular location indicated by IHC. (J) Western blotting showed phosphorylation of JNK1 (p45) and JNK2 (p54) in NEMOf/f mice after Jo2. JNK1 and GAPDH act as loading controls. Bars, 50 µm. Data are representative of three independent experiments. n = 4. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (NEMOf/f vs. NEMOΔhepa). §§, P < 0.01; §§§, P < 0.001 (NEMOf/f vs. Jo2/NEMOf/f). Error bars represent SD.

or Create an Account

Close Modal
Close Modal